New summit seeks to shape the future of longevity in clinical practice, with a clarion call for evidence-based education for physicians.
Once an area of medicine overshadowed by skepticism, the field of longevity medicine is now gaining scientific and clinical credibility – and serious investment. This October’s inaugural Global Longevity Summit represents a significant step forward in the formalization and professionalization of the field, bringing together leading researchers, clinicians, industry figures, and educators to foster meaningful dialogue around how emerging longevity science can be translated into responsible, evidence-based clinical practice.
The event, to be hosted in Geneva, Switzerland, seeks to set itself apart from the rising tide of commercially driven and influencer-led longevity content by grounding its discussions in peer-reviewed science and clinical experience. Delivered in partnership with the American Academy of Anti-Aging Medicine (A4M), attendees can expect a program that is both academically rigorous and clinically practical, with opportunities to engage directly with experts across multiple specialties. The takeaway is clear: the field requires actionable education that can be incorporated into practice, and a clearer path toward helping patients live longer, healthier lives.
Longevity.Technology: The Global Longevity Summit is the beginning of an ongoing series of meetings that aim to shape the direction of longevity medicine, set standards, and support real-world outcomes in patient care. At its core, the conference is focused on education – ensuring that clinicians have access to the latest research, protocols, and technologies, and are trained to apply them ethically and effectively. To learn more, we caught up with event organizer Doreen Brown, CEO of Informa Connect’s medical division.
As new players flood the consumer longevity market and biohackers dominate social media with a dizzying volume of healthspan-related content, Brown says the new summit is determined to bring rigor, standards and clinical accountability to the conversation.
“We’ve always worked to distinguish rigorous scientific research and data-driven education from what I would describe as today’s biohacking trend,” she says. “So, with this event, we’re investing in making sure evidence-based research and education reaches clinicians. We’re using this platform to bring together scientists, researchers, industry, and clinicians under one roof.”
Education is key
While Brown acknowledges the huge influx of investment in the field is bringing much needed attention to longevity, it also brings its challenges.
“A lot of startups are entering the space, and longevity is turning into a bit of a money grab for some,” she says. “A key challenge is all the noise – unless you’re a well-versed scientist or clinician, it’s easy to get distracted by it all. We want to cut through the noise and stay grounded in education.”
Major themes at the summit include the biological underpinnings of aging, the integration of diagnostics and early intervention into routine care, and the growing role of lifestyle medicine in preventing chronic diseases. Discussions will also explore cutting-edge developments such as biological aging clocks and their role in predicting health risks, evaluating therapies, and tracking the effects of interventions over time.
“This is about bringing top researchers, industry leaders, and physicians together to chart a path forward,” says Brown. “We’re not going to change the field in a single event, but through multiple gatherings and ongoing dialogue.”
Leading researchers assemble
From Steve Horvath and Gordan Lauc to Matt Kaeberlein and Andrea Maier, the summit has assembled a formidable group of speakers with extensive credentials in longevity science and medicine.
“We were always looking to bring in serious scientists and clinicians – that’s the only way we can start to move the needle,” says Brown. “They may not always be right, but their work is grounded in real research, and that’s where progress begins. We need more large-scale studies and outcome-based evidence – here’s the baseline, here’s the intervention, and here’s what changed – without that, we’re still shooting in the dark.”
According to Brown, the population health benefits of longevity medicine can only be realized through long-term, systemic change, and A4M’s involvement is key to achieving this.
“A4M has always focused on education – that’s what makes this partnership so compelling,” she says. “In the ideal future, everyone will have access to well-trained, longevity-focused physicians. That’s what we want to do – train doctors in evidence-based longevity and healthspan science they didn’t learn in medical school. Our mission to give them the tools they need to integrate longevity into their practices.”
Longevity’s future is bright
Addressing the increasing emergence of specialized longevity physicians in recent years, Brown says that many are well-informed, and should be lauded for pioneering the field. Although this isn’t always the case.
“There’s money to be made, and unfortunately, that also attracts people who aren’t qualified – opening clinics and using the word ‘longevity’ to capitalize on the trend,” she says. “This underscores the need for scientific rigor, proper credentialing, and the establishment of clear clinical standards to distinguish serious medical practice from the rest.
“That’s why we need to focus on what’s proven, safe, and science-based – not what a biohacker is doing. We want this event to highlight what’s real and serious versus what’s trending online. We have an obligation to accelerate education, and it’s incredibly exciting to bring all the right people together to work on this challenge. I believe the future of longevity is very, very bright indeed.”
Registration for the Global Longevity Summit is open – click HERE to be part of it.
